EP1990338A3
Biphenylcyclopropylamides as p-38 Kinase inhibitors
Abstract
Compounds and compositions for modulating the activity of p38 kinases are provided, including p38α and p38β kinase. Methods for treating, preventing or ameliorating one or more symptoms of a p38 kinase mediated disease or disorder are also provided.
Term
Term ended
Projected expiry passed 23 July 2024, 2.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO03032970A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-5 |
| WO03032972A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-5 |
| WO03032980A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-5 |
| WO03032987A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-5 |
| WO03093248A1 | Cites | World Intellectual Property Organization (WIPO) | PX | Search report | 1-5 |
33 members in 14 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 490096P | United States of America | – | |
| 49009603 | United States of America | P | |
| 04778988 | European Patent Office (EPO) | A |
Members33
| Document | Office | Kind | |
|---|---|---|---|
| US2005020590A1 | United States of America | A1 | |
| AU2004261589A1 | Australia | A1 | |
| CA2534990A1 | Canada | A1 | |
| WO2005012241A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2005012241A3 | World Intellectual Property Organization (WIPO) | A3 | |
| MXPA06000915A | Mexico | A | |
| EP1687284A2 | European Patent Office (EPO) | A2 | |
| BRPI0412918A | Brazil | A | |
| BRPI0412918A | Brazil | A | |
| CN1856480A | China | A | |
| JP2007500129A | Japan | A | |
| US2007111999A1 | United States of America | A1 | |
| AU2004261589B2 | Australia | B2 | |
| AU2008202641A1 | Australia | A1 | |
| EP1687284B1 | European Patent Office (EPO) | B1 | |
| EP1990338A2 | European Patent Office (EPO) | A2 | |
| AT412642T | Austria | T | |
| ATE412642T1 | Austria | T1 | |
| DE602004017494D1 | Germany | D1 | |
| CN100447137C | China | C | |
| CN101337944A | China | A | |
| EP1990338A3This record | European Patent Office (EPO) | A3 | |
| PT1687284E | Portugal | E | |
| ES2315703T3 | Spain | T3 | |
| PL1687284T3 | Poland | T3 | |
| US7700622B2 | United States of America | B2 | |
| US7754726B2 | United States of America | B2 | |
| US2010234404A1 | United States of America | A1 | |
| EP1990338B1 | European Patent Office (EPO) | B1 | |
| AT482205T | Austria | T | |
| ATE482205T1 | Austria | T1 | |
| DE602004029293D1 | Germany | D1 | |
| EP2251333A1 | European Patent Office (EPO) | A1 |
55 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Notification of lapseLapsedST | ST | FR | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Discontinued in the netherlands as no translation has been filedVDEP | VDEP | NL | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Designation fees paidAKX | AKX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Divisional application: reference to earlier applicationAC | AC | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1990338
- Application
- 81588659
Titles3
- German
- p-38-Kinasehemmer
- English
- Biphenylcyclopropylamides as p-38 Kinase inhibitors
- French
- Inhibiteurs de la kinase p-38
Classification
- CPC, 54
- A61K31/538
- A61K31/165
- A61K31/4245
- A61K31/4439
- A61K31/4965
- A61K31/517
- C07C237/38
- C07C237/42
- C07D213/82
- C07D239/42
- C07D239/74
- C07D239/82
- C07D239/88
- C07D249/08
- C07D271/10
- C07D413/04
- C07C2601/02
- A61P1/00
- A61P1/04
- A61P1/16
- A61P1/18
- A61P11/00
- A61P11/06
- A61P11/16
- A61P13/12
- A61P17/00
- A61P17/06
- A61P17/18
- A61P19/02
- A61P19/06
- A61P19/08
- A61P19/10
- A61P21/00
- A61P21/04
- A61P25/00
- A61P25/16
- A61P25/28
- A61P29/00
- A61P31/00
- A61P31/06
- A61P31/12
- A61P35/00
- A61P37/02
- A61P37/06
- A61P37/08
- A61P43/00
- A61P5/14
- A61P7/00
- A61P7/04
- A61P7/06
- A61P9/00
- A61P9/10
- A61P3/10
- Y02A50/30
- IPC, 8
- C07D271 10
- C07D413 04
- C07D239 88
- C07D213 82
- C07D239 42
- C07D239 82
- C07D239 74
- C07D249 08
Designated states28
- Contracting states, 28
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Poland
- Portugal
- Romania
and 4 moreShow fewer
- Sweden
- Slovenia
- Slovakia
- Türkiye